SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Interim Management Statement

23 Feb 2018 09:06

RNS Number : 7741F
British Smaller Companies VCT PLC
23 February 2018
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2017

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2017. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make good progress with total return rising to 214.8 pence per ordinary share; Net Asset Value ("NAV") stood at 78.4 pence per ordinary share. This is an increase of 1.4 pence per ordinary share in the quarter equivalent to 1.8% growth in the period.

Performance

31 December 2017

Movement

30 September 2017

Net Assets (£m)

85.1

1.1

84.0

NAV per share (PPS)

78.4p

1.4p

77.0p

Cumulative dividends paid (PPS)

136.4p

-

136.4p

Total Return (PPS)

214.8p

1.4p

213.4p

Shares in issue

108,607,183

(500,000)

109,107,183

 

The total return at 31 December 2017, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 214.8 pence per ordinary share compared to 213.4 pence per ordinary share at 30 September 2017.

The unaudited NAV per ordinary share as at 31 December 2017 was 78.4p pence per ordinary share (30 September 2017: 77.0 pence per ordinary share). Cumulative dividends paid were unchanged at 136.4 pence per ordinary share (30 September 2017: 136.4 pence per ordinary share).

Shares in issue

On 19 December 2017 the Company purchased 500,000 ordinary shares of 10 pence each at a price of 73.65 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 December 2017 was 108,607,183 (30 September 2017: 109,107,183). In addition, at 31 December 2017 the Company held 4,807,999 ordinary shares in treasury (30 September 2017: 4,307,999).

Net assets

Net assets at 31 December 2017 comprised the following:

£000

% of net assets

Unquoted investments at fair value

54,459

64.0

Quoted investments at bid price

2,205

2.6

Total investments

56,664

66.6

Fixed income government securities

708

0.8

Quoted funds

1,893

2.2

Cash and cash equivalents

24,378

28.6

Other net current assets

1,477

1.8

Net assets

85,120

100.0

 

The investment portfolio at 31 December 2017 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Intelligent Office

 4,960

5.8

ACC Aviation

 4,672

5.5

Mangar Health Limited

 3,962

4.7

GTK (Holdco) Limited

 2,964

3.5

Springboard Research Holdings Limited

 2,896

3.4

Matillion Limited

2,728

3.2

Business Collaborator Limited

 2,703

3.2

Gill Marine Holdings Limited

 2,569

3.0

Deep-Secure Limited

 2,550

3.0

KeTech Enterprises Limited

2,336

2.7

32,340

38.0

Other investments

24,324

28.6

Total investments

56,664

66.6

 

There were no investments during the period.

In the quarter to 31 December 2017 the realisation and repayment of investments generated proceeds of £1.4 million.

 

Portfolio Performance

Over the quarter to 31 December 2017 aggregate unrealised portfolio valuations have increased by £1.6 million. There were strong performances in the quarter from the investments in GTK, Matillion, Deep-Secure and Business Collaborator, offset by reductions from RMS, Sipsynergy and DisplayPlan.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 December 2017, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

Your Board remains encouraged by the increase in investment opportunities that it is seeing, although the conversion of this pipeline to new investments continues to be hampered by the slow granting of advance assurance from HMRC. The Company has just received advance assurances for two new investments (£3.3 million) which it is hoped will complete in the near future, and is awaiting assurance on one further investment of £1.3 million.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

23 February 2018

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTPGUCUPUPRUBW
Date   Source Headline
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:24 pmRNS1st Quarter Results
10th Sep 20212:06 pmRNSResult of AGM
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising
23rd Jul 202110:35 amRNSDirector/PDMR Shareholding
23rd Jul 202110:34 amRNSPayment of Dividend and Allotment of Shares
25th Jun 20219:28 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNSAnnual Financial Report
4th May 20219:14 amRNSDirector Declaration - Non-executive appointment
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 202110:55 amRNSInterim Management Statement
8th Mar 20212:20 pmRNSDirector/PDMR Shareholding
8th Mar 20212:19 pmRNSDirector/PDMR Shareholding
8th Mar 20212:10 pmRNSIssue of Equity and Close of Offer
22nd Feb 20214:15 pmRNSClose of Offer to Further Applications
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
15th Dec 202012:02 pmRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNSHalf-year Report
5th Oct 20209:53 amRNSIssue of Equity
28th Sep 20207:18 amRNSTransaction in Own Shares
10th Sep 20201:31 pmRNSResult of AGM
28th Aug 20207:50 amRNSAGM Statement
12th Aug 202010:00 amRNSInterim Management Statement to 30 June 2020
31st Jul 20209:36 amRNSPayment of dividend and issue of equity
29th Jun 202011:51 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSAnnual Financial Report
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
20th Mar 20204:00 pmRNSPayment of Dividend
20th Mar 20204:00 pmRNSTransaction in Own Shares
11th Feb 20207:19 amRNS3rd Quarter Results and announcement of dividend
19th Dec 201910:18 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSHalf-year Report to 30 September 2019
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value
11th Sep 20192:46 pmRNSAppointment of non-executive directors
11th Sep 201912:55 pmRNSResult of AGM
15th Aug 20193:14 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.